IGM Biosciences (NASDAQ:IGMS) Lowered to “Sell” Rating by Wall Street Zen
Wall Street Zen lowered shares of IGM Biosciences (NASDAQ:IGMS – Free Report) from a hold rating to a sell rating in a research note issued to investors on Saturday morning. IGM Biosciences Price Performance NASDAQ:IGMS opened at $1.32 on Friday. The business has a fifty day simple moving average of $1.22 and a two-hundred day […]
